CD14 employs hydrophilic regions to 'capture' lipopolysaccharides

Journal of Immunology

Volumn 164, Issue 6, 2000, Pages 3255-3263

  Cunningham, Mark D ^a   Shapiro, Robert A ^c   Seachord, Carrie ^a   Ratcliffe, Kent ^b   Cassiano, Linda ^b   Darveau, Richard P ^d  

^a BRISTOL MYERS SQUIBB   (United States)

^b AMGEN INC   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN;

ARTICLE; BACTERIAL INFECTION; ESCHERICHIA COLI; HELICOBACTER PYLORI; HYDROPHILICITY; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0034653474     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.6.3255     Document Type: Article

References (35)

1. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431.
2. Schumann, R. R., S. R. Leong, G. W. Flaggs, P. W. Gray, S. D. Wright, J. C. Mathison, P. S. Tobias, and R. J. Ulevitch. 1990. Structure and function of lipopolysaccharide binding protein. Science 249:1429.
3. Cleveland, M. G., J. D. Gorham, T. L. Murphy, E. Tuomanen, and K. M. Murphy. 1996. Lipoteichoic acid preparations of Gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infect. Immun. 64:1906.
4. Pugin, J., I. D. Heumann, A. Tomasz, V. V. Kravchenko, Y. Akamatsu, M. Nishijima, M. P. Glauser, P. S. Tobias, and R. J. Ulevitch. 1994. CD14 is a pattern recognition receptor. Immunity 1:509.
5. Sugawara, S., R. Arakaki, H. Rikiishi, and H. Takada. 1999. Lipoteichoic acid acts as an antagonist and an agonist of lipopolysaccharide on human gingival fibroblasts and monocytes in a CD14-dependent manner. Infect. Immun. 67:1623.
6. Dziarski, R., R. I. Tapping, and P. S. Tobias. 1998. Binding of bacterial peptidoglycan to CD14. J. Biol. Chem. 273:3680.
7. Gupta, D., Q. Wang, C. Vinson, and R. Dziarski. 1999. Bacterial peptidoglycan induces CD14-dependem activation of transcription factors CREB/ATF and AP-1. J. Biol. Chem. 274:14012.
8. Giambartolomei, G. H., V. A. Dennis, B. L. Lasater, and M. T. Philipp. 1999. Induction of pro- and anti-inflammatory cytokines by Borrelia burgdorferi lipoproteins in monocytes is mediated by CD14. Infect. Immun. 67:140.
9. Sellati, T. J., D. A. Bouis, R. L. Kitchens, R. P. Darveau, J. Pugin, R. J. Ulevitch, S. C. Gangloff, S. M. Goyert, M. V. Norgard, and J. D. Radolf. 1998. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytic cells via a CD14-dependent pathway distinct from that used by lipopolysaccharide. J. Immunol. 160:5455.
10. Wooten, R. M., T. B. Morrison, J. H. Weis, S. D. Wright, R. Thieringer, and J. J. Weis. 1998. The role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferi. J. Immunol. 160:5485.
11. Kitchens, R. L., and R. S. Munford. 1995. Enzymatically deacylated lipopolysaccharide (LPS) can antagonize LPS at multiple sites in the LPS recognition pathway. J. Biol. Chem. 270:9904.
12. Delude, R. L., R. Savedra, Jr., H. Zhao, R. Thieringer, S. Yamamoto, M. J. Fenton, and D. T. Golenbock. 1995. CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. Proc. Natl. Acad. Sci. USA 92:9288.
13. Wright, S. D. 1995. CD14 and innate recognition of bacteria. J. Immunol. 155:6.
14. McGinley, M. D., L. O. Narhi, M. J. Kelley, E. Davy, J. Robinson, M. F. Rohde, S. D. Wright, and H. S. Lichenstein. 1995. CD14: physical properties and identification of an exposed site that is protected by lipopolysaccharide. J. Biol. Chem. 270:5213.
15. Juan, T. S., E. Hailman, M. J. Kelley, L. A. Busse, E. Davy, C. J. Empig, L. O. Narhi, S. D. Wright, and H. S. Lichenstein. 1995. Identification of a lipopolysaccharide binding domain in CD14 between amino acids 57 and 64. J. Biol. Chem. 270:5219.
16. Stelter, F., M. Bernheiden, R. Menzel, R. S. Jack, S. Witt, X. Fan, M. Pfister, and C. Schutt. 1997. Mutation of amino acids 39-44 of human CD14 abrogates binding of lipopolysaccharide and Escherichia coli. Eur. J. Biochem. 243: 100.
17. Juan, T. S., E. Hailman, M. J. Kelley, S. D. Wright, and H. S. Lichenstein. 1995. Identification of a domain in soluble CD14 essential for lipopolysaccharide (LPS) signaling but not LPS binding. J. Biol. Chem. 270:17237.
18. Shapiro, R. A., M. D. Cunningham, K. Ratcliffe, C. Seachord, J. Blake, J. Bajorath, A. Aruffo, and R. P. Darveau. 1997. Identification of CD14 residues involved in specific lipopolysaccharide recognition. Infect. Immun. 65:293.
19. Krieger, M., S. Acton, J. Ashkenas, A. Pearson, M. Penman, and D. Resnick. 1993. Molecular flypaper, host defense, and atherosclerosis: structure, binding properties, and functions of macrophage scavenger receptors. J. Biol. Chem. 268: 4569.
20. Cunningham, M. D., C. Seachord, K. Ratcliffe, B. Bainbndge, A. Aruffo, and R. P. Darveau. 1996. Helicobacter pylori and Porphyromonas gingivalis lipopolysaccharides are poorly transferred to recombinant soluble CD14. Infect. Immun. 64:3601.
21. Darveau, R. P., and R. E. Hancock. 1983. Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J. Bacteriol. 155:831.
22. Westphal, O., and K. Jann. 1965. Bacterial lipopolysaccharides: extraction with phenol-water and further applications of the procedure. In Methods in Carbohydrate Chemistry. R. L. Whistler, ed. Academic Press, New York, p. 83.
23. Moran, A. P., I. M. Helander, and T. U. Kosunen. 1992. Compositional analysis of Helicobacter pylori rough-form lipopolysaccharides. J. Bacteriol 174:1370.
24. Ogawa, T. 1993. Chemical structure of lipid A from Porphyromonas (Bacteroides) gingivalis lipopolysaccharide. FEBS Lett. 332:197.
25. Takada, H., and S. Kotani. 1992. Bacterial endoloxic lipopolysaccharides. In Molecular Biochemistry and Cellular Biology, Vol. 1. D. C. Morrison and J. L. Ryan, eds. CRC Press, Boca Raton, p. 107.
26. Darveau, R. P., C. M. Belton, R. A. Reife, and R. J. Lament. 1998. Local chemokine paralysis, a novel pathogenic mechanism for Porphyromonas gingivalis. Infect. Immun. 66:1660.
27. Cunningham, M. D., J. Bajorath, J. E. Somerville, and R. P. Darveau. 1999. Escherichia coli and Porphyromonas gingivalis lipopolysaccharide interactions with CD14: implications for myeloid and nonmyeloid cell activation. Clin. Infect. Dis. 28:497.
28. Juan, T. S., M. J. Kelley, D. A. Johnson, L. A. Busse, E. Hailman, S. D. Wright, and H. S. Lichenstein. 1995. Soluble CD14 truncated at amino acid 152 binds lipopolysaccharide (LPS) and enables cellular response to LPS. J. Biol. Chem. 270:1382.
29. Viriyakosol, S., and T. N. Kirkland. 1995. A region of human CD14 required for lipopolysaccharide binding. J. Biol. Chem. 270:361.
30. Wilson, I. A., and R. L. Stanfield. 1994. Ab-antigen interactions: new structures and new conformational changes. Curr. Opin. Struct. Biol. 4:857.
31. Wilson, I. A., R. L. Stanfield, J. M. Rini, J. H. Arevalo, U. Schulze-Gahmen, D. H. Fremont, and E. A. Stura. 1991. Structural aspects of Abs and Ab-antigen complexes. Ciba Found. Symp. 159:13.
32. Darveau, R. P., M. D. Cunningham, T. Bailey, C. Seachord, K. Ratcliffe, B. Bainbridge, M. Dietsch, R. C. Page, and A. Aruffo. 1995. Ability of bacteria associated with chronic inflammatory disease to stimulate E-selectin expression and promote neutrophil adhesion. Infect. Immun. 63:1311.
33. Ogawa, T., H. Uchida, and K. Amino. 1994. Immunobiological activities of chemically defined lipid A from lipopolysaccharides of Porphyromonas gingivalis. Microbiology 140:1209.
34. Perez-Perez, G. I., V. L. Shepherd, J. D. Morrow, and M. J. Blaser. 1995. Activation of human THP-1 cells and rat bone marrow-derived macrophages by Helicobacter pylori lipopolysaccharide. Infect. immun. 63:1183.
35. Shapira, L., S. Takashiba, S. Amar, and T. E. Van Dyke. 1994. Porphyromonas gingivalis lipopolysaccharide stimulation of human monocytes: dependence on serum and CD14 receptor. Oral Microbiol. Immunol. 9:112.